These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17762173)

  • 41. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Nitschke R
    Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Frequency of delta F508 mutation in Venezuelan patients with cystic fibrosis].
    Morales-Machin A; Borjas-Fajardo L; Pineda L; González S; Delgado W; Zabala W; Fernández E
    Invest Clin; 2004 Jun; 45(2):121-30. PubMed ID: 15211979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insight into cystic fibrosis by structural modelling of CFTR first nucleotide binding fold (NBF1).
    Annereau JP; Stoven V; Bontems F; Barthe J; Lenoir G; Blanquet S; Lallemand JY
    C R Acad Sci III; 1997 Feb; 320(2):113-21. PubMed ID: 9181119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mismatch cleavage detects base deletion in cystic fibrosis gene.
    Hsu IC; Highsmith WE; Xu J; Kong D
    Biotechniques; 1998 Oct; 25(4):692-6. PubMed ID: 9793654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genistein potentiates wild-type and delta F508-CFTR channel activity.
    Hwang TC; Wang F; Yang IC; Reenstra WW
    Am J Physiol; 1997 Sep; 273(3 Pt 1):C988-98. PubMed ID: 9316420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines.
    Haws CM; Nepomuceno IB; Krouse ME; Wakelee H; Law T; Xia Y; Nguyen H; Wine JJ
    Am J Physiol; 1996 May; 270(5 Pt 1):C1544-55. PubMed ID: 8967457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of F508-del Function by Transcomplementation: The Partners Meet in the Endoplasmic Reticulum.
    Bergbower EAS; Sabirzhanova I; Boinot C; Guggino WB; Cebotaru L
    Cell Physiol Biochem; 2019; 52(6):1267-1279. PubMed ID: 31026390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benzo(c)quinolizinium drugs inhibit degradation of Delta F508-CFTR cytoplasmic domain.
    Stratford FL; Pereira MM; Becq F; McPherson MA; Dormer RL
    Biochem Biophys Res Commun; 2003 Jan; 300(2):524-30. PubMed ID: 12504115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.
    Okiyoneda T; Harada K; Takeya M; Yamahira K; Wada I; Shuto T; Suico MA; Hashimoto Y; Kai H
    Mol Biol Cell; 2004 Feb; 15(2):563-74. PubMed ID: 14595111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
    Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mouse model for the cystic fibrosis delta F508 mutation.
    van Doorninck JH; French PJ; Verbeek E; Peters RH; Morreau H; Bijman J; Scholte BJ
    EMBO J; 1995 Sep; 14(18):4403-11. PubMed ID: 7556083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.
    Bali V; Lazrak A; Guroji P; Matalon S; Bebok Z
    PLoS One; 2016; 11(5):e0155882. PubMed ID: 27214033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation and characterization of a delta F508 cystic fibrosis mouse model.
    Colledge WH; Abella BS; Southern KW; Ratcliff R; Jiang C; Cheng SH; MacVinish LJ; Anderson JR; Cuthbert AW; Evans MJ
    Nat Genet; 1995 Aug; 10(4):445-52. PubMed ID: 7545494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries.
    Feingold J; Guilloud-Bataille M; De Crozes D
    Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
    Scott-Ward TS; Amaral MD
    FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular localisation of the most common mutant form of the CF gene protein, delta F508-CFTR.
    Morris MR; Pereira MM; Hallett MB; McPherson MA; Dormer RL
    Biochem Soc Trans; 1998 Aug; 26(3):S293. PubMed ID: 9766012
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluorescence-based, multiplex allele-specific PCR (MASPCR) detection of the delta F508 deletion in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Fortina P; Conant R; Parrella T; Rappaport E; Scanlin T; Schwartz E; Robertson JM; Surrey S
    Mol Cell Probes; 1992 Aug; 6(4):353-6. PubMed ID: 1382222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.